Avantor(US:AVTR) Prnewswire·2025-12-01 21:19Core Viewpoint - A class action lawsuit has been filed against Avantor, Inc. for allegedly misleading investors about the company's competitive position and the impact of increased competition on its financial performance [1][3]. Group 1: Allegations and Financial Impact - The lawsuit claims that Avantor's competitive positioning was weaker than publicly represented, and that the company was negatively affected by increased competition [3]. - On October 29, 2025, Avantor reported a net loss of $712 million for Q3 2025, attributed to a non-cash goodwill impairment charge of $785 million, which was partly due to competitive pressures that impacted margins [4]. - Following the announcement of weak financial results, Avantor's stock price fell by more than 23%, from $15.08 to $11.58 per share [4]. Group 2: Class Action Participation - Shareholders who purchased Avantor common stock during the class period (March 5, 2024 - October 28, 2025) may be eligible to participate in the class action [1][5]. - Interested shareholders must submit their papers to the court by December 29, 2025, to serve as lead plaintiff, representing other class members [5]. Group 3: Company Background - Avantor, Inc. provides scientific products and services across various sectors, including biotechnology, pharmaceuticals, and healthcare [1].